Article Text

PDF
BET 1: A glass half full? Thrombolysis for the treatment of submassive pulmonary embolism
  1. Liam Barrett1,
  2. Dan Horner2
  1. 1 University of Birmingham, Birmingham, UK
  2. 2 Salford Royal NHS Foundation Trust, Salford, UK
  1. Correspondence to Dan Horner, Emerge (Research Office), Emergency Department, Manchester Royal Infirmary, Manchester M13 9WL, UK; katharine.wylie{at}cmft.nhs.uk

Abstract

A short-cut review was carried out to establish whether thrombolysis in addition to therapeutic anticoagulation could be of benefit in submassive (intermediate risk) pulmonary embolism (PE). 64 directly relevant papers were found using the reported search strategy. Of these, three presented the best evidence to answer the clinical question. The author, date and country of publication, patient group studied, study type, relevant outcomes, results and study weaknesses of these best papers are tabulated. It is concluded that there is insufficient evidence to support the routine use of adjuvant thrombolytic therapy at any dose for patients with submassive PE. Carefully selected patients with a low bleeding risk who attribute high importance to functional outcome may stand to benefit.

  • emergency department

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.